SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-057878
Filing Date
2023-12-15
Accepted
2023-12-15 16:06:26
Documents
5
Period of Report
2024-01-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20013527x2_def14a.htm DEF 14A 161147
2 logo_rmehra.jpg GRAPHIC 14340
3 logo_seelostherapeutics.jpg GRAPHIC 38514
4 ny20013527x2_pc01.jpg GRAPHIC 730433
5 ny20013527x2_pc02.jpg GRAPHIC 709163
  Complete submission text file 0001140361-23-057878.txt   2216832
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Filer) CIK: 0001017491 (see all company filings)

IRS No.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22245 | Film No.: 231490323
SIC: 2834 Pharmaceutical Preparations